Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic”

Diabetes & Metabolic Syndrome Clinical Research & Reviews(2020)10.1016/j.dsx.2020.07.041Source: DataRank Database

Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic” is a research paper published in Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Carlos M. Ferrario ORCID

Live enrichment

PubMed:32755842 PMC:PMC7380253 OpenAlex:https://openalex.org/W3043903967

National Heart and Lung Institute

National Institutes of Health (NIH) .

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7380253

publisherhttps://api.elsevier.com/content/article/PII:S1871402120302885?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1871402120302885?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.dsx.2020.07.041

Fields of Study

Renin-Angiotensin System StudiesHormonal Regulation and HypertensionApelin-related biomedical researchAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsBetacoronavirusCOVID-19Coronavirus InfectionsDiabetes MellitusHumansPandemicsPneumonia, ViralSARS-CoV-2

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2Angiotensin-Converting Enzyme InhibitorsDiabetes MellitusHumansPneumonia, ViralCoronavirus InfectionsAngiotensin Receptor AntagonistsPandemics

Keywords

PandemicCoronavirus disease 2019 (COVID-19)Angiotensin Receptor BlockersAngiotensin-converting enzymeDiabetes mellitusAngiotensin-converting enzyme 22019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacologyMedicineEnzymeVirologyInternal medicineEndocrinologyChemistryBiochemistryDiseaseInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being

Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic”

FAIR Checklist

Authors (1)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)